Walleye Trading’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,600
Closed -$373K 5564
2021
Q3
$373K Buy
1,600
+1,178
+279% +$247K ﹤0.01% 3221
2021
Q2
$87K Buy
+422
New +$86.8K ﹤0.01% 4435
2020
Q4
Sell
-1,765
Closed -$323K 4739
2020
Q3
$323K Buy
+1,765
New +$332K ﹤0.01% 2612
2019
Q4
Sell
-258
Closed -$44.4K 4414
2019
Q3
$41K Buy
+258
New +$51.4K ﹤0.01% 3619
2018
Q4
Sell
-7,646
Closed -$2.16M 4940
2018
Q3
$2.16M Buy
+7,646
New +$2.24M 0.01% 1245
2017
Q1
Sell
-100
Closed -$15K 4884
2016
Q4
$15K Sell
100
-90
-47% -$13K ﹤0.01% 4184
2016
Q3
$24K Buy
+190
New +$22.9K ﹤0.01% 4111
2016
Q1
Sell
-680
Closed -$65K 5549
2015
Q4
$77K Sell
680
-682
-50% -$75.4K ﹤0.01% 3515
2015
Q3
$149K Buy
1,362
+1,162
+581% +$124K ﹤0.01% 2595
2015
Q2
$19K Buy
+200
New +$18.7K ﹤0.01% 4002
2015
Q1
Sell
-348
Closed -$29K 4233
2014
Q4
$29K Buy
+348
New +$26.7K ﹤0.01% 3495
2014
Q3
Sell
-555
Closed -$34 4208
2014
Q2
$34 Buy
555
+551
+13,775% +$32.5K ﹤0.01% 3035
2014
Q1
$0 Buy
+4
New +$246 ﹤0.01% 3701
2013
Q3
Sell
-380
Closed -$27K 3062
2013
Q2
$27K Buy
+380
New +$25.1K ﹤0.01% 2437

Other funds holding ICUI

Walleye Trading's ICUI Position: Q4 2021 in Review

Walleye Trading sold out of ICU Medical (ICUI) in Q4 2021, closing a stake of 1,600 shares — an estimated $373K sold.

Walleye Trading first reported a position in ICUI in Q2 2013 and held it in 14 quarters. The position peaked at $2.16M in Q3 2018. 294 funds tracked by Wall St. Rank hold ICUI as of Q4 2021.

  • Walleye Trading reported no remaining ICU Medical position as of Q4 2021 after selling out during the quarter.
  • Walleye Trading sold 1,600 ICU Medical shares in Q4 2021, an estimated $373K.
  • Walleye Trading first reported a position in ICU Medical in Q2 2013 and held it in 14 quarters.
  • Walleye Trading's ICU Medical position peaked at $2.16M in Q3 2018.
  • 294 funds tracked by Wall St. Rank held ICU Medical as of Q4 2021.

Based on Walleye Trading's 13F filing for Q4 2021, filed 14 Feb 2022.